Silvant Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $560K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $139K | Hold |
|
|||||
|
2022
Q2 | $201K | Hold |
|
|||||
|
2022
Q1 | $244K | Hold |
|
|||||
|
2021
Q4 | $283K | Sell |
|
|||||
|
2021
Q3 | $323K | Hold |
|
|||||
|
2021
Q2 | $341K | Hold |
|
|||||
|
2021
Q1 | $407K | Hold |
|
|||||
|
2020
Q4 | $495K | Hold |
|
|||||
|
2020
Q3 | $294K | Sell |
|
|||||
|
2020
Q2 | $357K | Hold |
|
|||||
|
2020
Q1 | $203K | Hold |
|
|||||
|
2019
Q4 | $195K | Hold |
|
|||||
|
2019
Q3 | $196K | Hold |
|
|||||
|
2019
Q2 | $290K | Hold |
|
|||||
|
2019
Q1 | $317K | Hold |
|
|||||
|
2018
Q4 | $199K | Hold |
|
|||||
|
2018
Q3 | $349K | Hold |
|
|||||
|
2018
Q2 | $351K | Hold |
|
|||||
|
2018
Q1 | $233K | Buy |
|